DOI: 10.36347/sjds.2021.v08i10.003

Pages: 307-310

Obstructive Sleep Apnea is a complex disorder and has the characteristic finding of collapse of the upper airway during sleep. The effects of OSA may be widespread and can affect the cardiovascular, pulmonary, and neurocognitive systems. OSA has higher prevalence in men than women. The clinical symptoms can help to identify patients with OSA but it is also common to have no signs and symptoms in the initial stages. Obesity can be a contributing factor for OSA. OSA is identified as a major factor for cardiovascular morbidity such a systemic and pulmonary hypertension, heart failure, atrial fibrillation, and other arrhythmias. The screening for OSA includes the use of symptom questionnaire, CBCT for airway measurements, and confirmed by polysomnography. The management primarily includes the use of continuous positive airway pressure, orthodontic options, and surgical options.